Please be aware that this event has been cancelled.
The Multi-Omics Based Drug Discovery & Development Summit 2025 Official Program
It’s evident that multi-omics is taking the field by storm, with experts realising the potential of omics analysis for unlocking novel therapeutic insights.
The Multi-Omics Summit has been designed to enable you to optimize data integration, storage, and large-scale analysis, enabling the implementation of multi-omics across target discovery, precision medicine, clinical development, and beyond.
Uniting a diverse range of biopharma leaders and academic KOLS, including Johnson & Johnson, Sonoma Biotherapeutics, Amgen, Resilient Biotics, Gilead, and more, this is a unique opportunity to connect with fellow omics experts to advance therapeutic development.
Having Trouble Downloading the Brochure?
Let us know and we'll email it to you instead!
Official Brochure
What To Expect
 |
Transform multi-omics data integration and analysis to generate comprehensive insights, with interactive discussion sessions |
|
Realize the full potential of multi-omics analysis to optimize therapeutic development, with case study presentations from biopharma leaders |
|
Achieve efficient multi-omics workflows across project teams by learning from industry leaders successfully implementing multi-omics |